Could a natural brain booster help stroke survivors walk again?

NCT ID NCT07519044

Recruiting now Disease control Sponsor: Xuanwu Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding GM1, a natural brain substance, to standard clot-removal treatment helps people recover better after a severe stroke. About 868 adults in China who have a blocked artery in the front part of the brain will receive either GM1 or a placebo daily for up to 7 days. The goal is to see if more patients achieve independence in daily activities 90 days later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GM1 (a natural brain compound given as an IV infusion)
What this could lead to: If it works, this could mean better recovery and less disability for people who have a major stroke and undergo clot removal.
What could go wrong: This is a Phase 4 trial, but GM1's benefit specifically for clot-removal patients is unknown. The study is still recruiting, so results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral artery occlusion ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE STROKE

Contacts and locations

Locations

Heze Municipal Hospital
RECRUITING

Shandong, Heze, China
Xuanwu Hospital, Capital Medical University.
RECRUITING

Beijing, Beijing Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.